University of Dundee

all News

February 2013

  • 05 Feb 2013

    A review in Nature by Grahame Hardie of the Division of Cell Signalling and Immunology at CLS and Luke O’Neill (Trinity College Dublin) suggests that AMPK-activating drugs have both anti-cancer and anti-inflammatory properties.

October 2012

May 2012

April 2012

March 2012

February 2012

  • 28 Feb 2012

    Scientists at the College of Life Sciences, studying an important tumour suppressor, which is involved in at least a quarter of all cancers, have uncovered new ways in which it works. The research team at the have been studying the tumour suppressor protein PTEN, which when `turned off’ or damaged drives the development of many cancers.

Pages